Form 483

Hemcare of Oregon, Inc. Form 483, 2017-04-26

FDA issued a Form 483 to Hemcare of Oregon, Inc. on 2017-04-26 with 16 public-safe observations.

483· Form 483 issuedHuman Drugs16 observations

Hemcare of Oregon, Inc. · Wilsonville, United States · Issued April 26, 2017

Overview

  • 16 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

26 Apr 2017
21 CFR 211.166(a)

Results not used for expiration dates, storage cond.

Cited by Nancy E Byerly

26 Apr 2017
21 CFR 211.166(a)

Results not used for expiration dates, storage cond.

Cited by Nancy E Byerly

26 Apr 2017
21 CFR 211.166(a)

Results not used for expiration dates, storage cond.

Cited by Nancy E Byerly

26 Apr 2017
21 CFR 211.166(a)

Results not used for expiration dates, storage cond.

Cited by Nancy E Byerly

26 Apr 2017
21 CFR 211.182

Personnel dating/signing equipment log

Cited by Nancy E Byerly

Inspected site

HOHemcare of Oregon, Inc.Wilsonville, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.166(a)Cited across public-safe Form 483 observations4x
21 CFR 211.182Cited across public-safe Form 483 observations4x
21 CFR 211.46(b)Cited across public-safe Form 483 observations4x
21 CFR 211.80(b)Cited across public-safe Form 483 observations4x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 16 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere